Back to Glossary

    Sites & Operations

    Clinical Trial Startup

    Clinical trial startup is the set of activities between protocol finalization and first-patient-in (FPI), including regulatory submissions, IRB/IEC approvals, contract and budget execution, site selection and qualification, central lab and IRT setup, IP labeling, and site initiation visits.

    Startup is the most time-compressible phase of a trial; industry medians range from 6; 9 months for global Phase 3 studies, with site-by-site activation often the rate-limiting step. Tufts CSDD data show that startup represents 30; 40% of the total trial timeline.

    AI-enabled startup reduces timelines through parallelized site identification, template-driven essential document collection, automated budget benchmarking, and predictive analytics on contract negotiation cycles.

    Related terms

    See how Kitsa applies this in your trials

    Kitsa's agentic AI compresses protocol development, site selection, and patient pre-screening from months into weeks.

    Request a demo